resveratrol has been researched along with 6-ketoprostaglandin f1 alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awad, AB; Burr, AT; Fink, CS | 1 |
| Lakota, K; Mrak-Poljsak, K; Rozman, B; Sodin-Semrl, S | 1 |
2 other study(ies) available for resveratrol and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Effect of resveratrol and beta-sitosterol in combination on reactive oxygen species and prostaglandin release by PC-3 cells.
Topics: 6-Ketoprostaglandin F1 alpha; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Drug Synergism; Humans; Male; Phospholipases A; Prostaglandins; Reactive Oxygen Species; Resveratrol; Sitosterols; Stilbenes | 2005 |
Increased responsiveness of human coronary artery endothelial cells in inflammation and coagulation.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antioxidants; Blood Coagulation; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Plant Extracts; Resveratrol; Stilbenes; Tea; Thromboplastin | 2009 |